Curable, Inc. engages in the provision of genome analytics services. Its services include genetic analysis, genetic diagnosis, and development of single nucleotide polymorphism analysis busine diagnostic marker. The company was founded on May 26, 2000 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company